Christine Heller

2.8k total citations
37 papers, 1.4k citations indexed

About

Christine Heller is a scholar working on Hematology, Surgery and Internal Medicine. According to data from OpenAlex, Christine Heller has authored 37 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Hematology, 8 papers in Surgery and 8 papers in Internal Medicine. Recurrent topics in Christine Heller's work include Blood Coagulation and Thrombosis Mechanisms (18 papers), Hemophilia Treatment and Research (11 papers) and Venous Thromboembolism Diagnosis and Management (8 papers). Christine Heller is often cited by papers focused on Blood Coagulation and Thrombosis Mechanisms (18 papers), Hemophilia Treatment and Research (11 papers) and Venous Thromboembolism Diagnosis and Management (8 papers). Christine Heller collaborates with scholars based in Germany, Israel and United States. Christine Heller's co-authors include Ulrike Nowak‐Göttl, R. Schobeß, Karin Kurnik, W. Kreuz, Ronald Sträter, Andrea Kosch, Thomas Klingebiel, Inmaculada Martinez‐Saguer, E. Rusicke and Ralf Junker and has published in prestigious journals such as Circulation, Blood and Neurology.

In The Last Decade

Christine Heller

32 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Christine Heller Germany 18 1.0k 484 304 291 216 37 1.4k
R. Schobeß Germany 23 1.5k 1.5× 625 1.3× 414 1.4× 162 0.6× 315 1.5× 39 1.9k
Vânia M. Morelli Norway 16 519 0.5× 404 0.8× 65 0.2× 134 0.5× 147 0.7× 72 990
Mariana Bonduel Argentina 14 406 0.4× 213 0.4× 113 0.4× 90 0.3× 134 0.6× 35 669
Katia Paciaroni Italy 18 924 0.9× 460 1.0× 37 0.1× 376 1.3× 125 0.6× 40 1.2k
L Brisson Canada 11 914 0.9× 897 1.9× 482 1.6× 66 0.2× 366 1.7× 14 1.8k
W.B.J. Gerrits Netherlands 13 539 0.5× 306 0.6× 64 0.2× 122 0.4× 343 1.6× 24 1.3k
H. Vielhaber Germany 14 605 0.6× 295 0.6× 86 0.3× 53 0.2× 124 0.6× 25 734
Eugenia Biguzzi Italy 18 540 0.5× 207 0.4× 36 0.1× 120 0.4× 209 1.0× 50 929
F. R. Rosendaal Netherlands 9 1.2k 1.1× 810 1.7× 38 0.1× 231 0.8× 161 0.7× 11 1.4k
Graziella Saggiorato Italy 21 459 0.4× 196 0.4× 48 0.2× 155 0.5× 153 0.7× 44 1.0k

Countries citing papers authored by Christine Heller

Since Specialization
Citations

This map shows the geographic impact of Christine Heller's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christine Heller with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christine Heller more than expected).

Fields of papers citing papers by Christine Heller

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christine Heller. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christine Heller. The network helps show where Christine Heller may publish in the future.

Co-authorship network of co-authors of Christine Heller

This figure shows the co-authorship network connecting the top 25 collaborators of Christine Heller. A scholar is included among the top collaborators of Christine Heller based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christine Heller. Christine Heller is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Mackensen, Sylvia von, Ronald Fischer, Susan Halimeh, et al.. (2025). Health‐Related Quality of Life in Adult Patients With von Willebrand Disease From Germany: Results of the WIL‐QoL Study. Haemophilia. 32(1). 143–154.
2.
Halimeh, Susan, C. Wermes, Ronald Fischer, et al.. (2025). Clinical, Obstetric‐Gynaecological and HRQoL Data of Female VWD Patients in the WIL‐QoL Study. Haemophilia. 32(1). 174–184.
3.
Albinger, Nawid, Jordis Trischler, Christine Heller, et al.. (2024). Immune profiling and functional analysis of NK and T cells in ataxia telangiectasia. Frontiers in Immunology. 15. 1377955–1377955. 1 indexed citations
4.
Bidlingmaier, Christoph, Christine Heller, Florian Länger, et al.. (2024). Real-world usage and effectiveness of recombinant factor VIII/factor IX Fc in hemophilia A/B: final data from the 24-month, prospective, noninterventional PREVENT study in Germany. Research and Practice in Thrombosis and Haemostasis. 8(5). 102482–102482.
5.
Kenet, Gili, Ulrich C. Klostermeier, Frauke Degenhardt, et al.. (2016). Impact of high risk thrombophilia status on recurrence among children and adults with VTE: An observational multicenter cohort study. Blood Cells Molecules and Diseases. 62. 24–31. 8 indexed citations
6.
Kenet, Gili, Neil A. Goldenberg, Christine Heller, et al.. (2016). Impact of high‐risk thrombophilia status on recurrence among children with a first non‐central‐venous‐catheter‐associated VTE: an observational multicentre cohort study. British Journal of Haematology. 175(1). 133–140. 21 indexed citations
7.
Klamroth, Robert, Susanne Holzhauer, Rainer Zimmermann, Christine Heller, & Karin Kurnik. (2014). Beriate® P in the treatment of patients with haemophilia A: Results of a long-term pharmacovigilance study. Thrombosis Research. 134. S16–S21. 1 indexed citations
8.
Halimeh, Susan, Christoph Bidlingmaier, Christine Heller, et al.. (2013). Risk Factors for High-Titer Inhibitor Development in Children with Hemophilia A: Results of a Cohort Study. BioMed Research International. 2013. 1–7. 8 indexed citations
9.
Kreuz, W., E. Rusicke, Inmaculada Martinez‐Saguer, et al.. (2011). Home therapy with intravenous human C1‐inhibitor in children and adolescents with hereditary angioedema. Transfusion. 52(1). 100–107. 60 indexed citations
10.
11.
Martinez‐Saguer, Inmaculada, E. Rusicke, Emel Aygören‐Pürsün, et al.. (2010). Characterization of acute hereditary angioedema attacks during pregnancy and breast-feeding and their treatment with C1 inhibitor concentrate. American Journal of Obstetrics and Gynecology. 203(2). 131.e1–131.e7. 79 indexed citations
13.
Kenet, Gili, Fenella J. Kirkham, Thomas Niederstadt, et al.. (2007). Risk factors for recurrent venous thromboembolism in the European collaborative paediatric database on cerebral venous thrombosis: a multicentre cohort study. The Lancet Neurology. 6(7). 595–603. 128 indexed citations
14.
Klarmann, Dieter, Inmaculada Martinez Saguer, Markus B. Funk, et al.. (2007). Immune tolerance induction with mycophenolate‐mofetil in two children with haemophilia B and inhibitor. Haemophilia. 14(1). 44–49. 28 indexed citations
15.
Heinecke, Achim, et al.. (2003). Increased fasting total homocysteine plasma levels as a risk factor for thromboembolism in children. Thrombosis and Haemostasis. 91(2). 308–314. 24 indexed citations
16.
Heller, Christine & Ulrike Nowak‐Göttl. (2003). Maternal thrombophilia and neonatal thrombosis. Best Practice & Research Clinical Haematology. 16(2). 333–345. 10 indexed citations
18.
Heller, Christine, R. Schobeß, Karin Kurnik, et al.. (2000). Abdominal venous thrombosis in neonates and infants: role of prothrombotic risk factors - a multicentre case-control study. British Journal of Haematology. 111(2). 534–539. 95 indexed citations
19.
Heller, Christine, R. Schobeß, Karin Kurnik, et al.. (2000). Abdominal venous thrombosis in neonates and infants: role of prothrombotic risk factors – a multicentre case–control study. British Journal of Haematology. 111(2). 534–539. 102 indexed citations
20.
Heller, Christine, Sven Becker, I. Scharrer, & W. Kreuz. (1999). Prothrombotic risk factors in childhood stroke and venous thrombosis. European Journal of Pediatrics. 158(S3). S117–S121. 61 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026